Menniti F S, Knoth J, Peterson D S, Diliberto E J
J Biol Chem. 1987 Jun 5;262(16):7651-7.
The Km of dopamine beta-hydroxylase for its cofactor, ascorbic acid, was determined in situ in primary cultures of bovine adrenomedullary chromaffin cells and in isolated chromaffin vesicles. A range of intravesicular ascorbate concentrations in chromaffin cell cultures (1.1-31.2 mM) was achieved by varying the number and concentration of ascorbate additions to the culture media. The rate of octopamine synthesis from tyramine displayed a Michaelis-Menten relationship with respect to ascorbate concentration and an apparent Km of dopamine beta-hydroxylase for ascorbate of 15.0 +/- 2.0 mM was determined. In isolated chromaffin vesicles, with an initial intravesicular ascorbate concentration of approximately 10 mM, ascorbate consumption during beta-hydroxylation occurred as a first order process. This indicated that dopamine beta-hydroxylase was not saturated at this initial ascorbate concentration. When isolated chromaffin vesicles were prepared with different intravesicular ascorbate concentrations, the rate of octopamine synthesis displayed a Michaelis-Menten relationship with respect to ascorbate with an apparent Km of 17.0 +/- 5.0 mM. Ascorbate consumption also occurred as a first order process in ascorbate-loaded chromaffin-vesicle ghosts which had initial ascorbate concentrations of approximately 30 mM but which were depleted of other small molecules such as catecholamines. These results indicate that the in situ Km of dopamine beta-hydroxylase for ascorbate (approximately 15 mM) is 25-fold higher than it is for the purified or partially purified enzyme assayed under optimal conditions in vitro (0.6 mM). The factor(s) which decreases the enzyme affinity for ascorbate, relative to in vitro, resides in the chromaffin vesicle interior and is also retained in chromaffin-vesicle ghosts. The mechanism of this effect remains to be determined. The Km value determined in these experiments is close to the estimated intravesicular ascorbate concentration of bovine chromaffin granules in vivo (4), suggesting that the availability of ascorbate could become a factor in regulating the rate of dopamine beta-hydroxylation.
在牛肾上腺髓质嗜铬细胞原代培养物和分离的嗜铬小泡中,原位测定了多巴胺β-羟化酶对其辅因子抗坏血酸的米氏常数(Km)。通过改变向培养基中添加抗坏血酸的数量和浓度,在嗜铬细胞培养物中获得了一系列囊泡内抗坏血酸盐浓度(1.1 - 31.2 mM)。从酪胺合成章鱼胺的速率与抗坏血酸盐浓度呈现米氏关系,测定多巴胺β-羟化酶对抗坏血酸的表观Km为15.0±2.0 mM。在分离的嗜铬小泡中,初始囊泡内抗坏血酸浓度约为10 mM,β-羟化过程中抗坏血酸的消耗呈一级过程。这表明在此初始抗坏血酸浓度下多巴胺β-羟化酶未饱和。当用不同的囊泡内抗坏血酸浓度制备分离的嗜铬小泡时,章鱼胺合成速率与抗坏血酸呈现米氏关系,表观Km为17.0±5.0 mM。在初始抗坏血酸浓度约为30 mM但不含儿茶酚胺等其他小分子的抗坏血酸负载的嗜铬小泡空壳中,抗坏血酸的消耗也呈一级过程。这些结果表明,多巴胺β-羟化酶对抗坏血酸的原位Km(约15 mM)比在体外最佳条件下测定的纯化或部分纯化酶的Km(0.6 mM)高25倍。相对于体外,降低酶对抗坏血酸亲和力的因素存在于嗜铬小泡内部,并且也保留在嗜铬小泡空壳中。这种效应的机制尚待确定。在这些实验中测定的Km值接近体内牛嗜铬颗粒估计的囊泡内抗坏血酸浓度(4),这表明抗坏血酸的可用性可能成为调节多巴胺β-羟化速率的一个因素。